Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice

NCT00752973 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediculosis

Interventions

DRUG: MALG (malathion) Treatment

Sponsor

Sun Pharmaceutical Industries, Inc.